Mission

World-Class Cancer Care
In Your Own Backyard

World-Class
Close To Home. Closer To Heart.

As you or a loved one fight the unimaginable, we are right by your side, and right next door. Mission is a community-based healthcare team of cancer and blood specialists ready to provide you with the best possible care and treatment options for your needs. 

Since 1981, we’ve been quietly serving those with cancer and blood disorders in all of central Iowa’s major medical facilities. We are proud partners with the John Stoddard Cancer Center at Unity Point and the MercyOne Cancer Center and work with them closely in providing the best care to our patients. The level of cancer care we provide — with evidence-based treatments, tumor boards, genetic counseling, and clinical trials — matches or exceeds the care available in any community oncology practice anywhere in the country. 

Cancer Care. For Life.

Stories
Hear Their Stories
Cacy’s Story
Fred’s Story

Overcoming Is Underway

Community
Community-Based Network Of Physicians

  • NCI’s Cancer Moonshot – 1st Patient in the Nation

    The National Cancer Institute’s Cancer Moonshot Study is a trial examining patient’s tissue and blood at two different time points to identify how cancer changes over time (if it becomes resistant to certain therapies) and how we can use this data to shape treatment decisions in the future. Mission Cancer + Blood participates in the Iowa-Wide Oncology Research Coalition (I-WORC), which was one of ten sites awarded participation in this study.  Through our participation with I-WORC, Mission Cancer + Blood enrolled the first patient in the nation in the Cancer Moonshot!

  • Genetic Counseling Services

    Mission Cancer + Blood is proud to announce that we will now be offering genetic counseling services for patients followed by a Mission Cancer + Blood physician.  This is such an exciting development for patient care in Central Iowa!

  • Proud partners with the MercyOne Cancer Center, the John Stoddard Cancer Center at Unity Point, and The Iowa Clinic!

    Mission Cancer + Blood is a proud partner with MercyOne Cancer Center, the John Stoddard Cancer Center, and The Iowa Clinic.  Since 1981, Mission has had two goals:  (1) delivering excellent patient care; and, (2) being a great partner to the major medical systems in Iowa.  Through these partnerships, we assist with the delivery of coordinated cancer care in both cancer centers and work daily with our partners to ensure the best of care and treatment for our patients.

  • Quality Oncology Practice Initiative Certified

    Mission Cancer + Blood is a Quality Oncology Practice Initiative (QOPI®) Certified practice through the American Society of Clinical Oncology. The certification process creates a culture of excellence and self-examination that helps practices deliver the best care to their patients. By becoming QOPI Certified, our practice has demonstrated its commitment to quality to patients, payers, and the medical community.

  • We will meet you where you are – close to home!

    Mission strives to serve patients close to their home.  We have always worked very closely with independent county hospitals as well as hospitals owned by or affiliated with our partners MercyOne or Unity Point.

    Our Physician teams are traveling every day of the week all over the state of Iowa to ensure your care is received close to home.  Our teams love the weekly opportunity to practice in the smaller communities that make Iowa so special.

You Know About Mayo.
Now Learn About Us.

Know Us
Get The Inside Scoop Here
View Our Clinical Trials
Our Physicians

Locations

Locations
22 Outreach Locations Serving Local Communities
John Stoddard Cancer Center 1221 Pleasant St. Suite 100 Des Moines, IA 50309
(515) 282-2921
MercyOne Cancer Center 411 Laurel St. Suite A300 Des Moines, IA 50314
(515) 282-2921
MercyOne Clive Cancer Center 12495 University Ave. Suite 200 Clive, IA 50325
(515) 282-2921
23 Other Locations Various Community Locations Across Iowa
View All
View All News

News

FDA Approves New 6-Week Dosing for Keytruda for All Approved Adult Indications…

https://www.biospace.com/article/fda-approves-new-6-week-dosing-for-keytruda-which-benefits-patients-during-pandemic/ From Biospace.com Published: Apr 29, 2020 By Alex Keown Merck’s vaunted checkpoint inhibitor Keytruda has picked up another regulatory approval. The U.S. Food and Drug Administration…

Read More
View All Blogs

Blogs

How The In-Office Lab Team Positively Influences Patient Care

While the COVID-19 pandemic continues to create challenges and upend routines, the in-office lab team at Mission Cancer + Blood carries on together, working to…

Read More